Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Kathy Ordoñez, Jay Shendure, Ivan Trifunovich, Federica DiPalma

Premium

RainDance Technologies has appointed Kathy Ordoñez to its board of directors. She is senior vice president at Quest Diagnostics, and was previously CEO of Celera. She also held several senior positions at Hoffmann La-Roche and oversaw the formation of Roche Molecular Systems, where she served as president and CEO.


The Hudson Alpha Institute for Biotechnology has awarded Jay Shendure its HudsonAlpha Life Sciences Prize for his work in the development and application of genomic technology, including completing a detailed sequence of DNA from HeLa cells. Shendure will receive the award for early career scientists on November 19. Shendure is an associate professor in the department of genome sciences at the University of Washington.


WaferGen Biosystems' board of directors has appointed President and CEO Ivan Trifunovich to the additional post of chairman of the board. He replaces Alnoor Shivji, who has been chairman since 2002 and has resigned to focus on a new startup venture. WaferGen said Joel Kanter, who has been a director since 2007, will serve as lead independent director.


The UK's Genome Analysis Center has appointed Federica DiPalma to director of science, where she will be responsible for all aspects of TGAC's scientific strategy and vision. Previously, she was head of vertebrate and health genomics at TGAC and prior to joining TGAC, she was assistant director of vertebrate biology at the Broad Institute.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.